CompletedNCT03358277
Aripiprazole Added to Methylphenidate for Young People With ADHD and DMDD
About this title
Read the official source — NCT03358277Medication studyAges 7–17
Understand this study
Who was this study for?
Listed age limits: 7 years to 17 years.
Study information
Study start dateStarted: November 19, 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 58
- Sponsor
- Tri-Service General Hospital (TSGH)
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Not clearly listed
- Age range
- From 7 Years to 17 Years
- Official registry ID
- NCT03358277
- Official title
Show the full official title
Aripiprazole Added on Methylphenidate in the Treatment of Youths With Comorbid ADHD and DMDD
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Locations not listed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Tri-Service General Hospital (TSGH), a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including MPH + APZ.
Who was this study for?
Listed age limits: 7 years to 17 years.
